메뉴 건너뛰기
Hospital Pharmacist
Volumn 13, Issue 2, 2006, Pages 45-47
The models used for health economic analysis
Author keywords

[No Author keywords available]
Indexed keywords

COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; HEALTH CARE; HEALTH CARE QUALITY; HEALTH ECONOMICS; PHARMACIST; PROFESSIONAL PRACTICE; QUALITY OF LIFE; SHORT SURVEY;
EID: 33645224418     PISSN: 13527967     EISSN: 13527967     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (6)
References (13)
  • 1
    • 0033019606 scopus 로고    scopus 로고
    • Cost-effectiveness of Viridal Duo compared to MUSE and Viagra in the treatment of erectile dysfunction in the UK - A preliminary model
    • Plumb JM, Guest JF. Cost-effectiveness of Viridal Duo compared to MUSE and Viagra in the treatment of erectile dysfunction in the UK - a preliminary model. Journal of Medical Economics 1999;2:65-83.
    • (1999) Journal of Medical Economics , vol.2 , pp. 65-83
    • Plumb, J.M.1    Guest, J.F.2
  • 2
    • 0027772390 scopus 로고
    • Markov models in medical decision making: A practical guide
    • Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Medical Decision Making 1993;13:322-38.
    • (1993) Medical Decision Making , vol.13 , pp. 322-338
    • Sonnenberg, F.A.1    Beck, J.R.2
  • 3
    • 0033769420 scopus 로고    scopus 로고
    • Economic impact of tibolone compared with continuous-combined hormone replacement therapy in the management of postmenopausal women with climacteric symptoms in the UK
    • Plumb JM, Guest JF. Economic impact of tibolone compared with continuous-combined hormone replacement therapy in the management of postmenopausal women with climacteric symptoms in the UK. Pharmacoeconomics 2000;18:477-86.
    • (2000) Pharmacoeconomics , vol.18 , pp. 477-486
    • Plumb, J.M.1    Guest, J.F.2
  • 4
    • 13744252173 scopus 로고    scopus 로고
    • Health economics in the genomic age
    • Szucs TD. Health economics in the genomic age. Recent Results Cancer Research 2005;166:299-313.
    • (2005) Recent Results Cancer Research , vol.166 , pp. 299-313
    • Szucs, T.D.1
  • 5
    • 3542998742 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence and its value judgments
    • Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329:224-7.
    • (2004) BMJ , vol.329 , pp. 224-227
    • Rawlins, M.D.1    Culyer, A.J.2
  • 6
    • 0034884103 scopus 로고    scopus 로고
    • Economics and ethics in health care
    • Culyer AJ. Economics and ethics in health care. Journal of Medical Ethics 2001;27:217-22.
    • (2001) Journal of Medical Ethics , vol.27 , pp. 217-222
    • Culyer, A.J.1
  • 7
    • 0038350663 scopus 로고    scopus 로고
    • The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations
    • Jackson BR, Busch MP, Stramer SL, AuBuchon JP. The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 2003;43:721-9.
    • (2003) Transfusion , vol.43 , pp. 721-729
    • Jackson, B.R.1    Busch, M.P.2    Stramer, S.L.3    Aubuchon, J.P.4
  • 8
    • 0031181172 scopus 로고    scopus 로고
    • Risk attitude and time discounting
    • Chapman G. Risk attitude and time discounting. Medical Decision Making 1997;17:355-6.
    • (1997) Medical Decision Making , vol.17 , pp. 355-356
    • Chapman, G.1
  • 9
    • 0034826916 scopus 로고    scopus 로고
    • Cost-effectiveness analysis with risk aversion
    • Zivin JG. Cost-effectiveness analysis with risk aversion. Health Economics 2001;10:499-508.
    • (2001) Health Economics , vol.10 , pp. 499-508
    • Zivin, J.G.1
  • 10
    • 0030981648 scopus 로고    scopus 로고
    • Incorporating risk attitude into Markov-process decision models: Importance for individual decision making
    • Cher DJ, Miyamoto J, Lenert LA. Incorporating risk attitude into Markov-process decision models: importance for individual decision making. Medical Decision Making 1997;17:340-50.
    • (1997) Medical Decision Making , vol.17 , pp. 340-350
    • Cher, D.J.1    Miyamoto, J.2    Lenert, L.A.3
  • 11
    • 0344824461 scopus 로고    scopus 로고
    • An introduction to health economics
    • Fleurence R. An introduction to health economics. Pharmaceutical Journal 2003;271:679-81.
    • (2003) Pharmaceutical Journal , vol.271 , pp. 679-681
    • Fleurence, R.1
  • 12
    • 0034501072 scopus 로고    scopus 로고
    • The global burden of disease study: A useful projection of future global health?
    • Cohen J. The global burden of disease study: a useful projection of future global health? Journal of Public Health Medicine 2000;22:518-24.
    • (2000) Journal of Public Health Medicine , vol.22 , pp. 518-524
    • Cohen, J.1
  • 13
    • 0025727231 scopus 로고
    • The healthy-years equivalents: How to measure them using the standard gamble approach
    • Mehrez A, Gafni A. The healthy-years equivalents: how to measure them using the standard gamble approach. Medical Decision Making 1991;11:140-6.
    • (1991) Medical Decision Making , vol.11 , pp. 140-146
    • Mehrez, A.1    Gafni, A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.